Evidence map›Paper›PMID 31801223›Full record

ArticleInternational journal of molecular sciences2019

Integration of Epigallocatechin Gallate in Gelatin Sponges Attenuates Matrix Metalloproteinase-Dependent Degradation and Increases Bone Formation.

Anqi Huang, Yoshitomo Honda, Peiqi Li, Tomonari Tanaka, Shunsuke Baba

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Epigallocatechin-3-Gallate Protects HDrug design, development and therapy · 2020
    Article
  15. Role of matrix metalloproteinases in bone regeneration: Narrative review.Journal of oral biology and craniofacial research
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anqi HuangDepartment of Oral Implantology, Osaka Dental University, 1-5-17, Otemae, Chuo-ku, Osaka 540-0008, Japan.
Yoshitomo HondaInstitute of Dental Research, Osaka Dental University, 8-1, Kuzuhahanazonocho, Hirakata, Osaka 573-1121, Japan.ORCID 0000-0002-4392-2318
Peiqi LiDepartment of Oral Implantology, Osaka Dental University, 1-5-17, Otemae, Chuo-ku, Osaka 540-0008, Japan.
Tomonari TanakaGraduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.ORCID 0000-0002-7050-9043
Shunsuke BabaDepartment of Oral Implantology, Osaka Dental University, 1-5-17, Otemae, Chuo-ku, Osaka 540-0008, Japan.
Osaka Dental University · JPKyoto Institute of Technology · JP

Funding

Japan Society for the Promotion of Science 16K12883, 16K11667, 16K11821, 17K17227, and 18H02986Osaka Dental University grant no. 18-1Otsuka Toshimi Scholarship Foundation grant no. 18-306
6 · The paper itself

Abstract

Matrix metalloproteinase (MMP)-2 and MMP-9 are well-known gelatinases that disrupt the extracellular matrix, including gelatin. However, the advantages of modulating MMP expression in gelatin-based materials for applications in bone regenerative medicine have not been fully clarified. In this study, we examined the effects of epigallocatechin gallate (EGCG), a major polyphenol catechin isolated from green tea, on MMP expression in gelatin sponges and its association with bone formation. Four gelatin sponges with or without EGCG were prepared and implanted into bone defects for up to 4 weeks. Histological and immunohistological staining were performed. Micro-computed tomography was used to estimate the bone-forming capacity of each sponge. Our results showed that EGCG integration attenuated MMP-2 (70.6%) and -9 expression (69.1%) in the 1 week group, increased residual gelatin (118.7%), and augmented bone formation (101.8%) in the 4 weeks group in critical-sized bone defects of rat calvaria compared with vacuum-heated gelatin sponges without EGCG. Moreover, vacuum-heated gelatin sponges with EGCG showed superior bone formation compared with other sponges. The results indicated that integration of EGCG in gelatin-based materials modulated the production and activity of MMP-2 and -9 in vivo, thereby enhancing bone-forming capacity.

Indexed as

Absorbable ImplantsAldehydesAnimalsBiocompatible MaterialsBone RegenerationBone ResorptionCatechinCell LineCell ProliferationGelatinMaleMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsOsteoblastsRats4-hydroxy-2-nonenalAldehydesBiocompatible MaterialsCatechinepigallocatechin gallateGelatinMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsMmp2 protein, ratMmp9 protein, ratanti-inflammatory reactionbiomaterialsbone formationcatechinmatrix metalloproteinase

Identifiers

PMID31801223
PMCPMC6929197
OpenAlexW2989672342

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.